Jaden Schaefer

There's a bunch of others.

For now, I think Lotus's kind of main competitor, like differentiator is price.

Their entire thing is free.

And of course, you know, some people are like, well, how long can you sustain free?

I mean, they have licensed doctors reviewing these files.

So I'm not sure if they're volunteering their time or Lotus is just kind of taking a hit at the beginning to try to, you know, onboard more people.

Their CEO said that the future monetization options might include something like a subscription or sponsored programs, but right now they're intentionally postponing making money, just trying to get users, I think, and their immediate goal is to basically refine the product, build trust, and just get as many patients using it as possible.

This is a healthcare system that is very used to long waits and kind of rushed visits.

And we hear a lot on the news about like doctors getting burnout and stuff.

And so I think because of this, Lotus is basically betting that AI is kind of, if you mix it with a human and you have a human kind of overseeing everything, you can turn what people are already doing informally into something that looks and feels like real care.

Like I already go to chat GPT and ask all of these questions and put symptoms in.

And I mean, OpenAI knows that, that's why they launched OpenAI Health.

And so making this more formal and saying, look, you had the whole conversation, now just like get it reviewed by a doctor and you can go get your prescription, I think is a very, very smart direction.

I'm excited to see what happens with this company and I'll keep you guys all up to date on it in the future.

Thanks so much for tuning into the podcast.

Make sure to go check out AIbox.ai if you want to get all of the top AI models in one place for $20 a month.

There's a link in the description to AIbox.ai.

Thanks so much for tuning in and I'll catch you in the next episode.

Welcome to the podcast.

I'm your host, Jaden Schaefer.